These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque. Rabbani LE; Loscalzo J Atherosclerosis; 1994 Jan; 105(1):1-7. PubMed ID: 8155083 [TBL] [Abstract][Full Text] [Related]
7. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels. Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067 [TBL] [Abstract][Full Text] [Related]
8. Contribution of the hemostatic system to angiogenesis in cancer. Wojtukiewicz MZ; Sierko E; Rak J Semin Thromb Hemost; 2004 Feb; 30(1):5-20. PubMed ID: 15034794 [TBL] [Abstract][Full Text] [Related]
9. [Assessment of the hemostatic system in healthy preterm and fullterm newborns]. Pinacho A; Páramo JA Rev Med Univ Navarra; 1993; 38(2):23-30. PubMed ID: 14735720 [TBL] [Abstract][Full Text] [Related]
10. The coagulation and fibrinolysis systems and atherosclerosis. Tanaka K; Sueishi K Lab Invest; 1993 Jul; 69(1):5-18. PubMed ID: 8331898 [No Abstract] [Full Text] [Related]
11. The relation between atherosclerosis and thrombosis. Loscalzo J Circulation; 1992 Dec; 86(6 Suppl):III95-9. PubMed ID: 1424055 [TBL] [Abstract][Full Text] [Related]
12. [Standardization of methods for studying fibrinolysis]. García Frade LJ; Obispo TM Sangre (Barc); 1993 Aug; 38(4):265-6. PubMed ID: 8235938 [No Abstract] [Full Text] [Related]
13. [Role of proteases, plasminogen activators, fibrin fibrinogen degradation products and fibrinopeptides in the growth and development of neoplasms and neoplasm metastases]. Farbiszewski R Postepy Hig Med Dosw; 1984; 38(2):133-55. PubMed ID: 6393101 [No Abstract] [Full Text] [Related]
14. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin. Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600 [TBL] [Abstract][Full Text] [Related]
15. Activation of plasma coagulation by retransfusion of unwashed drainage blood after hip joint arthroplasty: a prospective study. Duchow J; Ames M; Hess T; Seyfert U J Arthroplasty; 2001 Oct; 16(7):844-9. PubMed ID: 11607899 [TBL] [Abstract][Full Text] [Related]
16. Release of fibrinolytic enzymes by macrophages in response to soluble fibrin. Sherman LA; Lee JL; Stewart CC J Reticuloendothel Soc; 1981 Nov; 30(5):317-29. PubMed ID: 7198690 [No Abstract] [Full Text] [Related]
17. Fibrinogen/fibrin in atherogenesis. Smith EB; Thompson WD; Crosbie L; Stirk CM Eur J Epidemiol; 1992 May; 8 Suppl 1():83-7. PubMed ID: 1387095 [TBL] [Abstract][Full Text] [Related]
18. Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids. Crutchley DJ; Conanan LB; Maynard JR Ann N Y Acad Sci; 1981; 370():609-16. PubMed ID: 6455956 [No Abstract] [Full Text] [Related]
19. [Mechanism of fibrinolysis (review of the literature)]. Kovalenko AN Vrach Delo; 1983 Jan; (1):10-5. PubMed ID: 6223445 [No Abstract] [Full Text] [Related]
20. Fibrin as a factor in atherogenesis. Smith EB; Thompson WD Thromb Res; 1994 Jan; 73(1):1-19. PubMed ID: 8178309 [No Abstract] [Full Text] [Related] [Next] [New Search]